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SUMM/VRY 
A study of renal biopsy in 13 lithium treated patients is reported. The light microscopic changes 
were non-specific and comprised glomerular hypercellularity ; cloudy swelling of the tubular epithelium and 
interstitial fibrosis. Correlation between structural changes and functional alterations could not be estab-
lished. The duration of therapy did not have any bearing on the intensity of the structural changes. No 
case of renal failure occurred in well controlled series as ours. 
The widespread use of Lithium in 
affective disorders especially in their pro-
phylaxis has necessitated a careful assess-
ment of renal structure and function in view 
of its reported nephrotoxic properties. Of 
late this has become an area of intense 
interest. 
Animal Studies t 
A few reports of renal damage due to 
lithium toxicity in experimental animals 
are available. Epithelial degeneration and 
dilatation of the distal part of the nephrons 
have been induced in dogs by Radomski 
et al. (1950). Degenerative changes in the 
proximal convoluted tubules in rats have 
been demonstrated by Schou (1958). Evan 
and Ollerich (1972) have shown ultra-
structural lesions in lithium treated rats 
with blood levels corresponding to the 
therapeutic range in the humans. They are 
characterised by an initial mitochondrial 
change with bulging of cytoplasm of the 
tubular cells followed by liquefaction, 
Karyolysis and karyorhexis of the distal 
convoluted tubules and the collecting ducts. 
Human Studies : 
The published reports on renal studies 
have revealed glomerular as well as tubular 
dysfunction. Serum creatinine, creatinine 
clearance, Cr EDTA clearance, B2 micro-
globulin excretion have been employed to 
test the integrity of the glomerular func-
tion while 24-hour urinary volume, ability 
for acidification, urine AVP assay, osmo-
larity and tubular proteinuria are applied 
for testing tubular functions (Hallgren et 
al., 1979 ; HuUin et al., 1979 ; Venkoba 
Rao, et al, 1979). 
The structural changes in the kidneys 
of patients on lithium have now been 
described and these are classifiable as (i) 
specific lesions due to lithium and (ii) 
Non-specific lesions. These latter though, 
occurring in lithium treated patients are 
noticeable also under other situations. 
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Specific Renal Lesions : 
The essential pathology is tubular in 
distribution and is restricted to the distal 
convoluted tubules and collecting ducts. 
The ultrastructural changes comprise appa-
rent swelling of the cytoplasm and mito-
chondria with the other intracellular 
organelles at the periphery of the cells. No 
cell necrosis is seen. These changes occur 
within a few days of the starting of lithium 
and are pharmacological rather than toxic 
in nature. They are reversible and are 
not seen following the cessation of therapy 
for a year. (The lithium ion is known 
to interfere with the action of Adenyl cyclase 
in the formation of cyclic AMP). The loca-
tion of the lesions is where the vasopressin 
receptors are thought to be and this lesion 
presumably is the basis for the "Arginine 
vasopressin resistant diabetes insipidus syn-
drome." This so-called "unique" lithium 
lesion has been reported from Australia 
by Burrows et al. (1978), appropriately so 
when Cade, an Australian gave us earlier 
lithium for use in MDPs. 
Non-specific renal lesions : 
Hestbach et al. (1977) described first 
what they believed to be the irreversible 
morphological lesion due to lithium and 
suspected them to be progressive. However, 
Davies and Kincaid-Smith (1979) have 
found that the changes occur not only in 
patients receiving lithium but also in those 
about to receive it. These non-specific 
changes consist of (i) glomerular sclerosis, 
(ii) tubular atrophy, (iii) interstitial fibrosis 
and (iv) cast formation. 
PRESENT STUDY 
The Lithium clinic has been func-
tioning in the Institute of Psychiatry, Govt. 
Rajaji Hospital and Madurai Medical Col-
lege, Madurai, for several years now and 
presently there are 105 patients on its rolls 
(M = 79 ; F=26). The age structure varied 
from 10 to over 70 years. The duration of 
treatment extended from a minimum of 
one year to over five years. The dose 
of lithium ranged from 750 mq. to 1500 mg. 
a day. The serum lithium levels were 
between 0.6 to 1.0 mEq./Lil. Earlier a report 
on renal functioning in lithium treated 
patients from the clinic has been published 
(Venkoba Rao et al., 1979). 
AIMS 
The aims of the study were— 
(i) to analyse the structural pathology 
of the kidneys of the patients re-
ceiving lithium ; and 
(ii) to correlate these with renal func-
tional abnormalities and the -dura-
tion of treatment with lithium. 
MATERIAL AND METHOD 
Thirteen amongst the 105 lithium 
patients attending the Lithium clinic, Insti-
tute of Psychiatry were chosen for renal 
puncture biopsy. They gave their willing 
consent for the procedure, which was car-
ried out by one of us (CLA). The criterion 
for selection for biopsy was administration of 
lithium for more than a year; the duration 
of treatment in these cases varied from 
1.25—5 years. Eleven fell under this 
category. In the other two, lithium was 
withheld by us for a period of 7 and 8 
months after a continuous administration 
for 2 and 2.5 years respectively. A preli-
minary plain picture of abdomen to visualise 
the life of the kidneys was taken in all 
the patients. They all went through the 
battery of renal function tests which have 
already been reported and mentioned earlier 
(Venkoba Rao et al., 1979). The biopsy 
tissue was examined under light microscopy 
with suitable stains. Excepting for post 
biopsy hematuria lasting for 24-48 hours 
in a few cases no other complications were 
observed in our series. 
OBSERVATIONS 
The histopathological changes observed 54  A. VENKOBA RAO tt. al. 
were as follows : 
(i) Glomerular hypercellularity (N=4) 
(Fig. 1). 
(ii) Cloudy swelling of the tubules 
(N=2) (Fig. 2). 
(iii) Interstitial fibrosis (N = 3) (Fig. 3) 
(iv) No changes were seen (N = 4). 
(Normal renal appearances). 
Of the two patients who were off lithium, 
one showed glomerular hypercellularity and 
another, normal appearance. The three 
other patients who showed normal renal 
appearances were on lithium for 1.25— 
5 years. The other pathological changes 
were all evident in patients who were con-
tinuing lithium. 
The intensity of the microscopic changes 
does not seem to be proportionate to the 
duration of lithium administration. This 
is brought out in Table 1. 
TABLE-1 
Pathological Changes No. of Duration oflithium 
cases therapy 
1. Glomerular 
hypercellularity. 4* 3.5—5 years 
2. Cloudy swelling of 
tubules. 2 2.5—3.5 „ 
3. Interstitial fibrosis 3 2.5—3.5 a„ 
4. No change 4* 1.25—5 
•One was "off" lithium. 
An analysis was made of the correla-
tion between renal function test findings 
in these cases and histopathological changes 
The analysis failed to reveal any sort of 
correlation. For example : Mrs. A who 
had low hydrogen ion excretion which is 
a tubular function was free from tubular 
pathology but showed glomerular hyper-
cellularity and interstitial fibrosis. Mrs. 
M who had polyuria which again is a tubular 
function had only glomerular hypercellular-
ity. 
DISCUSSION 
That renal changes set in both struc-
turally and functionally in lithium con-
sumers has been established. However, the 
percentage of patients developing this un-
toward effect is no higher than 12-15% 
and no lower than 6-8% (Rafaelsen, 1980). 
Though renal damage resulting in death 
from renal failure has been known to occur 
during lithium intoxication (Chapman & 
Lewis, i972) no mortality among lithium 
receivers under controlled conditions has 
so far been reported (Hallgren et al., 1979 ; 
Vestergaard et al., 1979). In our earlier 
report (Venkoba Rao et al., 1979) glomerular 
function was found to be normal while 
tubular concentrating and acidifying ability 
were decreased. These changes were not 
severe enough to warrant discontinuation 
of treatment. Our study confirmed poly-
uria and polydipsic action of lithium. 
Glen and his colleagues (1979) showed that 
there was no increase in mortality in a 
series of 810 patients exposed to lithium 
over a period of ten years compared to 
expectation. Lithium is definitely contra-
indicated in patients who have a poor renal 
function and in those with a history of 
nephritic problems (Lancet, 1979a). A 
complete initial assessment of renal function 
in prelithium stage and its periodic repeti-
tion is mandatory. It has been hypothesized 
that a 24-hour urine volume around 4000 
cc, 24-hour creatinine clearance below 
1.0 ml/sec (60 ml/min) and serum creatinine 
level of over 1.5 mg. per 100 ml. are indica-
tions for discontinuance of lithium. A 
24-hour thirst test is also recommended 
after consultation with nephrologist 
(Rafaelsen, 1980). 
But what about the changes in the 
renal architecture under lithium ? Are they 
due to lithium ? It was thought to be 
so when Hestbach and her co-workers (1977) 
reported chronic renal lesions in 13 patients 
treated with lithium for 1.5 to 14 years. 
In 8 of them the lithium intoxication was LITHIUM AND KIDNEY  55 
acute and other 5 had severe polyuria. 
However, subsequent work by Kincaid-
Smith et al. (1979) demonstrated that such 
changes were non-specific in nature and 
occurred in prelithium patients and also in 
patients receiving other neuroleptics. Hence, 
the evidence seems to be that lithium could 
be exonerated to some extent. The patho-
logical lesions observed in our thirteen 
cases fall under the non-specific types. 
Certain theories have been advanced 
to explain the renal lesions that tend to 
allay the apprehension over lithium neph-
rotoxicity. It is held that kidneys share 
the cardio-vascular changes that the MDPs 
are liable to and it is known now that the 
mortality amongst the MDPs is high from 
cardiovascular diseases (Glen et al., 1979). 
Nevertheless the renal lesions do not appear 
to be artherosclerotic in nature. It has 
also been suggested that the renal lesions 
may be due to a hypersensitivity response 
in patients with MDP and lithium, as any 
other drug may have just precipitated 
them. Hypothyroid state has also been 
invoked to explain the abnormal renal 
function. since such associational changes 
have been observed by Katz et al. (1975) 
and Salomon et al. (1967). However, 
Hallgren et al. (1979) have disproved this. 
In our series, there was one patient with 
hypothyroidism who showed normal renal 
appearance. Finally electrolyte abnormal-
ities have been described in a group of 
affectively ill patients and these may stem 
from renal pathology itself, not related to 
lithium exhibition (Goppen, 1970). Hence, 
the prevalent view appears to be that much 
more researching is needed before the renal 
dysfunction and pathology could be attri-
buted to lithium per se. 
In this context, the report of Hullin 
and others (1979) merit mention. A com-
parative study between lithium treated and 
control patients (on psychotorpic other 
than lithium) failed to reveal any signi-
ficant renal impairment in lithium group. 
Our observations that there is no correla-
tion between the renal function and struc-
tural changes find support in the report of 
Burrows et al. (1978) who showed a normal 
serum creatinine and a normal urine in 
spite of impressive morphological change 
in their material. Vastergaard et al. (1979) 
suggest that lithium induced kidney changes 
may be made less frequent if the patients are 
maintained on doses lower than the currently 
accepted levels as therapeutic but they 
caution this may jeopardise the expected 
prophylactic benefit. To suggest renal 
biopsy either before, during or after lithium 
therapy is a tall order since it is neither 
feasible nor practical and falls under an 
invasive investigaiton. We know that the 
prophylactic effect becomes operative after 
administration of lithium for 12-18 months. 
It is also important in this connection to 
note that the so-called therapeutic window, 
i.e., the gap between the therapeutic and 
toxic dose is narrow for lithium. Under 
such circumstances, a careful selection of 
cases, thorough urological assessment and 
periodic repetition of tests become abso-
lutely necessary. Appropriate measures to 
avoid lithium intoxication during infec-
tions, fluid loss and dehydration are to 
be instituted. There is no alternative to 
this until a clear cut picture emerges exo-
nerating lithium in the genesis of renal 
damage. An attitude of "cautions opti-
mism" as advised by Lancet (1979b) is 
called for at present. Under well organised 
and controlled conditions, lithium continues 
to be safe, a consensus arrived at the meeting 
of the Biological Psychiatry Section of 
W.P.A. on "Lithium treatment and Kidney 
damage" held at Copenhagen, October, 
1979. 
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